跳至主要内容
临床试验/NL-OMON50650
NL-OMON50650已完成不适用

Optimizing treatment dosage for depression and comorbid personality disorders: a randomized clinical trial - Optimizing treatment dosage for depression and personality disorders

Arkin, Amsterdam0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Age 18-65 years
  • DSM-IV diagnosis of a major depressive episode or dysthymia and
  • DSM-IV diagnoses of one or more personality disorders

排除标准

  • - Non-Dutch speakers/readers
  • -Psychotic symptoms, bipolar disorder or current extreme substance dependence.
  • -Immediate intensive treatment or hospitalization is needed, e.g. acute
  • suicidality.
  • - Pregnancy or other reasons why trial demands can*t be met
  • - Use of medication that influences mental functioning: antipsychotics,
  • moodstabilizers, benzodiazepines > 30mg oxazepam or equivalent per day.

研究者

发起方
Arkin, Amsterdam

相似试验

Optimizing treatment dosage for depression and... | 临床试验